Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ECE1 | P42892 | 6/20 | 0.64 |
| ▸ | ERAP2 | Q6P179 | 6/20 | 0.63 |
| ▸ | GHSR | Q92847 | 3/20 | 0.60 |
| ▸ | ACE | P12821 | 2/20 | 0.60 |
| ▸ | ERAP1 | Q9NZ08 | 4/20 | 0.58 |
| ▸ | IL1RN | P18510 | 4/20 | 0.58 |
| ▸ | ANPEP | P15144 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31004373 | 0.96 | ERAP2 (0.61) | ECE1ERAP2GHSRACEERAP1 | |
| SCHEMBL29819949 | 0.96 | GHSR (0.62) | ECE1ERAP2GHSRACEERAP1 | |
| SCHEMBL30788017 | 0.95 | ERAP2 (0.64) | ECE1ERAP2GHSRACEERAP1 | |
| SCHEMBL29531497 | 0.93 | ERAP2 (0.61) | ECE1ERAP2GHSRACEERAP1 | |
| SCHEMBL31004384 | 0.93 | ERAP2 (0.61) | ECE1ERAP2GHSRACEERAP1 | |
| SCHEMBL30788022 | 0.92 | ERAP2 (0.59) | ECE1ERAP2GHSRERAP1IL1RN | |
| SCHEMBL31232500 | 0.92 | ERAP2 (0.63) | ECE1ERAP2GHSRACEERAP1 | |
| SCHEMBL29519671 | 0.92 | ECE1 (0.65) | ECE1ERAP2ACEERAP1IL1RN | |
| SCHEMBL30921655 | 0.92 | GHSR (0.60) | ECE1ERAP2GHSRACE | |
| SCHEMBL31468798 | 0.92 | GHSR (0.60) | ECE1ERAP2GHSRACEERAP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4168116-A1 | TOPICAL FORMULATIONS OF (1S)-1-PHENYL-2-PYRIDIN-2-YLETHANAMINE | Biohaven Therapeutics Ltd. (US) | 2023-04-26 | — | — | EP | disclosed |